Baicalein Inhibits Streptococcus mutans Biofilms and Dental Caries-Related Virulence Phenotypes.
Aparna VijayakumarHema Bhagavathi SarveswariSahana VasudevanKarthi ShanmugamAdline Princy SolomonNeelakantan PrasannaPublished in: Antibiotics (Basel, Switzerland) (2021)
Dental caries, the most common oral disease, is a major public healthcare burden and affects more than three billion people worldwide. The contemporary understanding of the need for a healthy microbiome and the emergence of antimicrobial resistance has resulted in an urgent need to identify compounds that curb the virulence of pathobionts without microbial killing. Through this study, we have demonstrated for the first time that 5,6,7-trihydroxyflavone (Baicalein) significantly downregulates crucial caries-related virulence phenotypes in Streptococcus mutans. Baicalein significantly inhibited biofilm formation by Streptococcus mutans UA159 (MBIC50 = 200 μM), without significant growth inhibition. Notably, these concentrations of baicalein did not affect the commensal S. gordonii. Strikingly, baicalein significantly reduced cell surface hydrophobicity, autoaggregation and acid production by S. mutans. Mechanistic studies (qRT-PCR) showed downregulation of various genes regulating biofilm formation, surface attachment, quorum sensing, acid production and competence. Finally, we demonstrate the potential translational value of baicalein by reporting synergistic interaction with fluoride against S. mutans biofilms.
Keyphrases
- biofilm formation
- candida albicans
- pseudomonas aeruginosa
- staphylococcus aureus
- antimicrobial resistance
- escherichia coli
- healthcare
- cell surface
- cystic fibrosis
- mental health
- microbial community
- cell proliferation
- emergency department
- drinking water
- adverse drug
- genome wide
- transcription factor
- dna methylation
- cancer therapy
- oral health
- health information
- genome wide analysis